The proteomic landscape of glioblastoma recurrence reveals novel and targetable immunoregulatory drivers
Author:
Funder
CIHR Project Grant
NIH/NCI
Publisher
Springer Science and Business Media LLC
Subject
Cellular and Molecular Neuroscience,Neurology (clinical),Pathology and Forensic Medicine
Link
https://link.springer.com/content/pdf/10.1007/s00401-022-02506-4.pdf
Reference53 articles.
1. Behnan J, Finocchiaro G, Hanna G (2019) The landscape of the mesenchymal signature in brain tumours. Brain 142:847–866. https://doi.org/10.1093/brain/awz044
2. Brennan CW, Verhaak RG, McKenna A, Campos B, Noushmehr H, Salama SR et al (2013) The somatic genomic landscape of glioblastoma. Cell 155:462–477. https://doi.org/10.1016/j.cell.2013.09.034
3. Casey AE, Sinha A, Singhania R, Livingstone J, Waterhouse P, Tharmapalan P et al (2018) Mammary molecular portraits reveal lineage-specific features and progenitor cell vulnerabilities. J Cell Biol 217:2951–2974. https://doi.org/10.1083/jcb.201804042
4. Chen H, Boutros PC (2011) VennDiagram: a package for the generation of highly-customizable Venn and Euler diagrams in R. BMC Bioinform 12:35. https://doi.org/10.1186/1471-2105-12-35
5. Choi UY, Kang JS, Hwang YS, Kim YJ (2015) Oligoadenylate synthase-like (OASL) proteins: dual functions and associations with diseases. Exp Mol Med 47:e144. https://doi.org/10.1038/emm.2014.110
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Targeting axonal guidance dependencies in glioblastoma with ROBO1 CAR T cells;Nature Medicine;2024-08-02
2. Programmed cell death disrupts inflammatory tumor microenvironment (TME) and promotes glioblastoma evolution;Cell Communication and Signaling;2024-06-18
3. Blood-brain barrier penetrating nanosystems enable synergistic therapy of glioblastoma;Nano Today;2024-06
4. Basic Transcription Factor 3 Like 4 Enhances Malignant Phenotypes through Modulating Tumor Cell Function and Immune Microenvironment in Glioma;The American Journal of Pathology;2024-05
5. RND1 inhibits epithelial-mesenchymal transition and temozolomide resistance of glioblastoma via AKT/GSK3-β pathway;Cancer Biology & Therapy;2024-03-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3